The agency says the Johnson & Johnson coronavirus vaccine should have a warning for a potential risk for rare blood clots even though it believes the shot’s benefits outweigh risks. The agency did not recommend stopping use of the vaccine.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register. By continuing to use this site, you are consenting to our use of cookies.